Breast cancer scoring based on a multiplexed profiling of soluble and cell-associated (immune) markers facilitates the prediction of pembrolizumab therapy.
Saved in:
| Title: | Breast cancer scoring based on a multiplexed profiling of soluble and cell-associated (immune) markers facilitates the prediction of pembrolizumab therapy. |
|---|---|
| Authors: | Schweihofer, Verena1,2 (AUTHOR) Verena.Schweihofer@stud.uni-regensburg.de, Bruss, Christina1,2 (AUTHOR) Christina.Bruss@ukr.de, Seitz, Stephan1,2 (AUTHOR) Sseitz@csj.de, Glehr, Gunther2,3 (AUTHOR) Gunther.Glehr@ukr.de, Hetterich, Madeleine1,2 (AUTHOR) mhetterich@csj.de, Weber, Florian2,4 (AUTHOR) florian.weber@ukr.de, Hatzipanagiotou, Maria1,2 (AUTHOR) mhatzipanagiotou@csj.de, Álvarez, Miriam Fernández-Pacheco1,2 (AUTHOR) mfernandezpacheco@csj.de, Ortmann, Olaf1,2 (AUTHOR) Oortmann@csj.de, Brockhoff, Gero1,2 (AUTHOR) Gero.Brockhoff@ukr.de, Bauer, Richard J.2,5 (AUTHOR) Richard.Bauer@ukr.de, Wege, Anja Kathrin1,2 (AUTHOR) Anja.Wege@ukr.de |
| Source: | Cancer Cell International. 3/27/2025, Vol. 25 Issue 1, p1-16. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14752867 |
|---|---|
| DOI: | 10.1186/s12935-025-03729-7 |
